Search results
Results from the WOW.Com Content Network
USV Private Limited (formerly USV Limited) is an Indian multinational pharmaceutical and biotechnology company in Mumbai. [3] The company operates across 75 countries globally, [4] and is a leading producer of Metformin in India. [5] The company was founded by Vithal Balkrishna Gandhi.
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a
Alkem has 21 manufacturing facilities: 19 in India and 2 in the US. [5] These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US. [6]
Elder Pharmaceuticals Ltd is a pharmaceutical company headquartered in Mumbai, Maharashtra. [7] Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women's Healthcare, Wound Care and Nutraceuticals.
Rubicon Research was founded in 1999 by Pratibha Pilgaonkar, Sudhir Pilgaonkar, and Maharukh Rustomjee. In 2000 it started operations as an independent product development company, located in Bhandup, Mumbai, with three scientists in a 2,000 sq ft (190 m 2) laboratory.
Unichem Laboratories was founded in 1944 by Padma Bhushan Amrut V Mody, a pioneer in the Indian pharmaceuticals business.. The initial public offering of Unichem Laboratories Limited was in 1963, after its registration in 1962, [4] and the company was consequently listed on BSE Limited and NSE Limited.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
Cipla sells active pharmaceutical ingredients to other manufacturers as well as pharmaceutical and personal care products, [20] including the anti-depressant escitalopram oxalate, lamivudine, and fluticasone propionate. [21] Cipla is the world's largest manufacturer of antiretroviral drugs. [20] [22]